Risk factors for antimicrobial resistance among the Escherichia coli strains Isolated from Korean patients with acute uncomplicated cystitis: A prospective and nationwide study

Journal of Korean Medical Science

Volumn 25, Issue 8, 2010, Pages 1205-1209

  Lee, Gilho ^a   Cho, Yong Hyun ^b   Shim, Bong Suk ^c   Lee, Sang Don ^d  

^a Dankook University   (South Korea)

^b The Catholic University of Korea College of Medicine   (South Korea)

^c Ewha Womans University School of Medicine   (South Korea)

^d Pusan National University School of Medicine   (South Korea)

Author keywords

Ciprofloxacin; Cystitis; Escherichia coli; Resistance

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CEFAZOLIN; CIPROFLOXACIN; COTRIMOXAZOLE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CYSTITIS; DRUG EFFECT; ESCHERICHIA COLI; FEMALE; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; RISK FACTOR; SOUTH KOREA;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AMPICILLIN; ANTI-BACTERIAL AGENTS; CEFAZOLIN; CIPROFLOXACIN; CYSTITIS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; RISK FACTORS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 77956576751     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2010.25.8.1205     Document Type: Article

References (15)

1. Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997; 11: 551-81.
2. Kim ME, Ha US, Cho YH. Prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2006. Int J Antimicrob Agents 2008; 31 Suppl 1: S15-8.
3. Lee SJ, Cho YH, Kim BW, Lee JG, Jung SI, Lee SD, Lee SE, Kim ME, Choi YD, Rim JS, Sim BS, Cho IR, Ryu SB, Kim CS, Kim WJ, Lee TY. A multicenter study of antimicrobial susceptibility of uropathogens causing acute uncomplicated cystitis in woman. Korean J Urol 2003; 44: 697-701.
4. Arslan H, Azap OK, Ergönül O, Timurkaynak F; Urinary Tract Infection Study Group. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J Antimicrob Chemother 2005; 56: 914-8.
5. Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India. Ann Clin Microbiol Antimicrob 2007; 6: 4.
6. Gobernado M, Valdés L, Alós JI, García-Rey C, Dal-Ré R, García-de-Lomas J; Spanish Surveillance Group for Urinary Pathogens. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain. Rev Esp Quimioter 2007; 20: 68-76.
7. Gobernado M, Valdés L, Alós JI, Garcia-Rey C, Dal-Ré R, García-de-Lomas J; Spanish Surveillance Group for E. coli Urinary Pathogens. Quinolone resistance in female outpatient urinary tract isolates of Escherichia coli: age-related differences. Rev Esp Quimioter 2007; 20: 206-10.
8. Hillier S, Roberts Z, Dunstan F, Butler C, Howard A, Palmer S. Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study. J Antimicrob Chemother 2007; 60: 92-9.
9. Butler CC, Hillier S, Roberts Z, Dunstan F, Howard A, Palmer S. Antibiotic-resistant infections in primary care are symptomatic for longer and increase workload: outcomes for patients with E. coli UTIs. Br J Gen Pract 2006; 56: 686-92.
10. Goettsch W, van Pelt W, Nagelkerke N, Hendrix MG, Buiting AG, Petit PL, Sabbe LJ, van Griethuysen AJ, de Neeling AJ. Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands. J Antimicrob Chemother 2000; 46: 223-8.
11. Steinke DT, Seaton RA, Phillips G, MacDonald TM, Davey PG. Prior trimethoprim use and trimethoprim-resistant urinary tract infection: a nested case-control study with multivariate analysis for other risk factors. J Antimicrob Chemother 2001; 47: 781-7.
12. Kahlmeter G, Menday P, Cars O. Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection. J Antimicrob Chemother 2003; 52: 1005-10.
13. Colgan R, Johnson JR, Kuskowski M, Gupta K. Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis. Antimicrob Agents Chemother 2008; 52: 846-51.
14. George AM, Levy SB. Amplifiable resistance to tetracycline, chloramphenicol, and other antibiotics in Escherichia coli: involvement of a nonplasmid-determined efflux of tetracycline. J Bacteriol 1983; 155: 531-40.
15. Miró E, Vergés C, García I, Mirelis B, Navarro F, Coll P, Prats G, Martínez-Martínez L. Resistance to quinolones and beta-lactams in Salmonella enterica due to mutations in topoisomerase-encoding genes, altered cell permeability and expression of an active efflux system. Enferm Infecc Microbiol Clin 2004; 22: 204-11.